Testing effectiveness (Phase 2)Study completedNCT05972954
What this trial is testing
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
Who this might be right for
Primary Mitochondrial Disease
Omeicos Therapeutics GmbH 28
Showing 6 of 6 results